Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Kataoka, T. Matsumoto, M. Yokoyama, T. Okano, Y. Sakurai, S. Fukushima, K. Okamoto, G. Kwon (2000)
Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance.Journal of controlled release : official journal of the Controlled Release Society, 64 1-3
S. Mehta, J. Lai, D. Lu (1996)
Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy.Journal of microencapsulation, 13 3
H. Yanagie, K. Maruyama, T. Takizawa, O. Ishida, K. Ogura, T. Matsumoto, Y. Sakurai, T. Kobayashi, A. Shinohara, J. Rant, J. Skvarc, R. Ilić, G. Kuhne, M. Chiba, Y. Furuya, H. Sugiyama, T. Hisa, K. Ono, H. Kobayashi, M. Eriguchi (2006)
Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 60 1
WH Knoth, JC Sauer, DC England, WR Hertler, EL Murtterties (1964)
Chemistry of boranes. XIX. derivative chemistry of B10H10 -2 and B12H12 -2J. Am. Chem. Soc., 86
S. Sumitani, Motoi Oishi, Y. Nagasaki (2011)
Carborane confined nanoparticles for boron neutron capture therapy: Improved stability, blood circulation time and tumor accumulationReactive & Functional Polymers, 71
J. Kim, K. Emoto, M. Iijima, Y. Nagasaki, T. Aoyagi, T. Okano, Y. Sakurai, K. Kataoka (1999)
Core-stabilized Polymeric Micelle as Potential Drug Carrier: Increased Solubilization of TaxolPolymers for Advanced Technologies, 10
H. Hatanaka (1975)
A revised boron-neutron capture therapy for malignant brain tumorsJournal of Neurology, 209
M. Iijima, Y. Nagasaki, T. Okada, Masao Kato, K. Kataoka (1999)
Core-Polymerized Reactive Micelles from Heterotelechelic Amphiphilic Block CopolymersMacromolecules, 32
Annette Rösler, Guido Vandermeulen, H. Klok (2001)
Advanced drug delivery devices via self-assembly of amphiphilic block copolymers.Advanced drug delivery reviews, 53 1
Gong Wu, R. Barth, Weilian Yang, Robert Lee, W. Tjarks, M. Backer, J. Backer (2006)
Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.Anti-cancer agents in medicinal chemistry, 6 2
G. Gaucher, Marie-Hélène Dufresne, V. Sant, N. Kang, D. Maysinger, J. Leroux (2005)
Block copolymer micelles: preparation, characterization and application in drug delivery.Journal of controlled release : official journal of the Controlled Release Society, 109 1-3
L. Farr, W. Sweet, J. Robertson, C. Foster, H. Locksley, D. Sutherland, M. Mendelsohn, E. Stickley (1954)
Neutron capture therapy with boron in the treatment of glioblastoma multiforme.The American journal of roentgenology, radium therapy, and nuclear medicine, 71 2
A. Soloway, H. Hatanaka, M. Davis (1967)
Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds.Journal of medicinal chemistry, 10 4
A. Asbury, R. Ojemann, S. Nielsen, W. Sweet (1972)
NEUROPATHOLOGIC STUDY OF FOURTEEN CASES OF MALIGNANT BRAIN TUMOR TREATED BY BORON‐10 SLOW NEUTRON CAPTURE RADIATIONJournal of Neuropathology and Experimental Neurology, 31
Liu Yang, A. Ghzaoui, Suming Li (2010)
In vitro degradation behavior of poly(lactide)-poly(ethylene glycol) block copolymer micelles in aqueous solution.International journal of pharmaceutics, 400 1-2
D. Feakes, K. Shelly, M. Hawthorne (1995)
Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes.Proceedings of the National Academy of Sciences of the United States of America, 92
K. Maruyama, O. Ishida, S. Kasaoka, T. Takizawa, N. Utoguchi, A. Shinohara, M. Chiba, H. Kobayashi, M. Eriguchi, H. Yanagie (2004)
Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).Journal of controlled release : official journal of the Controlled Release Society, 98 2
Tiejun Li, J. Hamdi, M. Hawthorne (2006)
Unilamellar liposomes with enhanced boron content.Bioconjugate chemistry, 17 1
W. Knoth, J. Sauer, D. England, W. Hertler, E. Muetterties (1964)
Chemistry of Boranes. XIX.1 Derivative Chemistry of B10H10-2 and B12H12-2Journal of the American Chemical Society, 86
Yusuke Miyajima, Hiroyuki Nakamura, Y. Kuwata, Jong-Dae Lee, S. Masunaga, K. Ono, K. Maruyama (2006)
Transferrin-loaded nido-carborane liposomes: tumor-targeting boron delivery system for neutron capture therapy.Bioconjugate chemistry, 17 5
Jong-Dae Lee, M. Ueno, Yusuke Miyajima, Hiroyuki Nakamura (2007)
Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy.Organic letters, 9 2
C. Gibson, A. Staubus, R. Barth, Weilian Yang, N. Kleinholz, R. Jones, K. Green-church, Wemer Tjarks, A. Soloway (2002)
Electrospray ionization mass spectrometry coupled to reversed-phase ion-pair high-performance liquid chromatography for quantitation of sodium borocaptate and application to pharmacokinetic analysis.Analytical chemistry, 74 10
H. Ichikawa, E. Taniguchi, T. Fujimoto, Y. Fukumori (2009)
Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer.Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 67 7-8 Suppl
H. Yanagië, A. Ogata, H. Sugiyama, M. Eriguchi, Shinichi Takamoto, Hiroyuki Takahashi (2008)
Application of drug delivery system to boron neutron capture therapy for cancerExpert Opinion on Drug Delivery, 5
Thomas Diezi, Y. Bae, G. Kwon (2010)
Enhanced stability of PEG-block-poly(N-hexyl stearate l-aspartamide) micelles in the presence of serum proteins.Molecular pharmaceutics, 7 4
Nastassja Lewinski, V. Colvin, R. Drezek (2008)
Cytotoxicity of nanoparticles.Small, 4 1
S. Hagan, Allan Coombes, M. Garnett, S. Dunn, M. Davies, and Illum, S. Davis, S. Harding, S. and, P. Gellert (1996)
Polylactide−Poly(ethylene glycol) Copolymers as Drug Delivery Systems. 1. Characterization of Water Dispersible Micelle-Forming SystemsLangmuir, 12
Yuji Yamamoto, Y. Nagasaki, Y. Kato, Y. Sugiyama, K. Kataoka (2001)
Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge.Journal of controlled release : official journal of the Controlled Release Society, 77 1-2
R. Barth, J. Coderre, M. Vicente, T. Blue (2005)
Boron Neutron Capture Therapy of Cancer: Current Status and Future ProspectsClinical Cancer Research, 11
H. Yoo, Eun Lee, T. Park (2002)
Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages.Journal of controlled release : official journal of the Controlled Release Society, 82 1
H. Burt, Xichen Zhang, P. Toleikis, L. Embree, W. Hunter (1999)
Development of copolymers of poly(d,l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxelColloids and Surfaces B: Biointerfaces, 16
M. Davidson, T. Hibbert, J. Howard, A. Mackinnon, K. Wade (1996)
Definitive crystal structures of ortho-, meta- and para-carboranes: supramolecular structures directed solely by C–H⋯O hydrogen bonding to hmpa (hmpa = hexamethylphosphoramide)Chemical Communications
AK Asbury, Ojemann, SL Nielson, WH Sweet (1972)
Neuropathological study of fourteen cases of malignant brain tumor treated by boron-10 slow neutron capture therapyJ. Neuropathol Exp. Neurol., 31
H. Maeda, T. Sawa, T. Konno (2001)
Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.Journal of controlled release : official journal of the Controlled Release Society, 74 1-3
O. Ishida, K. Maruyama, H. Tanahashi, M. Iwatsuru, K. Sasaki, M. Eriguchi, H. Yanagie (2001)
Liposomes Bearing Polyethyleneglycol-Coupled Transferrin with Intracellular Targeting Property to the Solid Tumors In VivoPharmaceutical Research, 18
E. Wagner, D. Curiel, M. Cotten (1994)
Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosisAdvanced Drug Delivery Reviews, 14
S. Benhabbour, M. Parrott, S. Gratton, A. Adronov (2007)
Synthesis and Properties of Carborane-Containing Dendronized PolymersMacromolecules, 40
Rolf Barfh, A. Soloway, R. Fairchild, R. Brugger (1992)
Boron neutron capture therapy for cancer. Realities and prospectsCancer, 70
(1936)
Biological effects and therapeutic possibilities of neutron
Y. Matsumura, H. Maeda (1986)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.Cancer research, 46 12 Pt 1
C. Rijcken, Cor Snel, R. Schiffelers, C. Nostrum, W. Hennink (2007)
Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies.Biomaterials, 28 36
Gong Wu, R. Barth, Weilian Yang, Madhumita Chatterjee, W. Tjarks, M. Ciesielski, R. Fenstermaker (2004)
Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy.Bioconjugate chemistry, 15 1
Jaeyoung Lee, E. Cho, Kilwon Cho (2004)
Incorporation and release behavior of hydrophobic drug in functionalized poly(D,L-lactide)-block-poly(ethylene oxide) micelles.Journal of controlled release : official journal of the Controlled Release Society, 94 2-3
M. Ueno, H. Ban, K. Nakai, Ryu Inomata, Y. Kaneda, A. Matsumura, Hiroyuki Nakamura (2010)
Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.Bioorganic & medicinal chemistry, 18 9
Yutaka Mishima, M. Ichihashi, S. Hatta, C. Honda, K. Yamamura, Toshio Nakagawa (1989)
New thermal neutron capture therapy for malignant melanoma: melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial.Pigment cell research, 2 4
J. Godwin, L. Farr, W. Sweet, J. Robertson (1955)
Pathological study of eight patients with glioblastoma multiforme treated by neutroncapture therapy using boron 10Cancer, 8
D. Roberts, K. Suda, J. Samanen, D. Kemp (1980)
Pluripotential amino acids I. ()--dihydroxyborylphenylalanine (-Bph) as a precursor of -Phe and -Tyr containing peptides; specific tritiation of -Phe-containing peptides at a final step in synthesisTetrahedron Letters, 21
Michael Danquah, Tomoko Fujiwara, R. Mahato (2010)
Self-assembling methoxypoly(ethylene glycol)-b-poly(carbonate-co-L-lactide) block copolymers for drug delivery.Biomaterials, 31 8
C. Meo, L. Panza, D. Capitani, L. Mannina, A. Banzato, M. Rondina, D. Renier, A. Rosato, V. Crescenzi (2007)
Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.Biomacromolecules, 8 2
R. Barth, D. Adams, A. Soloway, F. Alam, M. Darby (1994)
Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy.Bioconjugate chemistry, 5 1
K. Kataoka, Atsushi Harada, Y. Nagasaki (2001)
Block copolymer micelles for drug delivery: design, characterization and biological significance.Advanced drug delivery reviews, 47 1
L. Gedda, P. Olsson, J. Pontén, J. Carlsson (1996)
Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy.Bioconjugate chemistry, 7 5
T. Verrecchia, G. Spenlehauer, D. Bazile, A. Murry-Brelier, Y. Archimbaud, M. Veillard (1995)
Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriersJournal of Controlled Release, 36
M. Yokoyama, T. Okano, Y. Sakurai, H. Ekimoto, Chieko Shibazaki, K. Kataoka (1991)
Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood.Cancer research, 51 12
H. Hacker, A. Soloway (1964)
PENETRATING OF BRAIN AND BRAIN TUMOR. V. COPPER-64 CHELATES.Toxicology and applied pharmacology, 6
S. Sumitani, Motoi Oishi, Tatsuya Yaguchi, Hiroki Murotani, Y. Horiguchi, Minoru Suzuki, K. Ono, H. Yanagie, Y. Nagasaki (2012)
Pharmacokinetics of core-polymerized, boron-conjugated micelles designed for boron neutron capture therapy for cancer.Biomaterials, 33 13
Sungwon Kim, Yunzhou Shi, Ji Kim, Kinam Park, Ji‐Xin Cheng (2010)
Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle–cell interactionExpert Opinion on Drug Delivery, 7
Hongtao Chen, Sungwon Kim, Wei He, Haifeng Wang, P. Low, Kinam Park, Ji‐Xin Cheng (2008)
Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo forster resonance energy transfer imaging.Langmuir : the ACS journal of surfaces and colloids, 24 10
X. Shuai, T. Merdan, A. Schaper, F. Xi, T. Kissel (2004)
Core-cross-linked polymeric micelles as paclitaxel carriers.Bioconjugate chemistry, 15 3
K Kataoka, A Harada, Y Nagasaki (2001)
Block copolymer micelles for drug delivery: design characterization and biological significanceAdv. Drug. Dliv. Rev., 47
Y. Bae, S. Fukushima, Atsushi Harada, K. Kataoka (2003)
Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change.Angewandte Chemie, 42 38
Muriel Stefani, J. Coudane, M. Vert (2006)
In vitro ageing and degradation of PEG–PLA diblock copolymer-based nanoparticlesPolymer Degradation and Stability, 91
R. O’Reilly, C. Hawker, K. Wooley (2006)
Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility.Chemical Society reviews, 35 11
H Hatanaka (1975)
A revised boron-neutron capture therapy for malignant brain tumors: II. Interim clinical result with the patients excluding previous treatmentsJ. Neurol., 209
V. Gómez‐Vallejo, J. Llop (2009)
Specific activity of [11C]CH3I synthesized by the "wet" method: main sources of non-radioactive carbon.Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 67 1
Wenjun Du, Zhiqiang Xu, Andreas Nyström, Ke-Xin Zhang, Jeffrey Leonard, K. Wooley (2008)
19F- and fluorescently labeled micelles as nanoscopic assemblies for chemotherapeutic delivery.Bioconjugate chemistry, 19 12
H. Hatanaka, Y. Nakagawa (1994)
Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy.International journal of radiation oncology, biology, physics, 28 5
H. Snyder, A. Reedy, W. Lennarz (1958)
Synthesis of Aromatic Boronic Acids. Aldehydo Boronic Acids and a Boronic Acid Analog of Tyrosine1Journal of the American Chemical Society, 80
For high-performance boron neutron capture therapy (BNCT), core-shell-type biodegradable nanoparticles possessing boron clusters in their cores are designed to improve their accumulation tendency in the tumor region. The copolymerization of styrene carrying carborane with a poly(ethylene glycol)-block-poly(lactide) copolymer (PEG-b-PLA) that possesses an acetal group at its PEG end and a methacryloyl group at its PLA end (acetal-PEG-b-PLA-MA) was performed in an aqueous medium. As the acetal-PEG-b-PLA-MA forms a polymeric micelle in an aqueous medium, the carborane monomer in the hydrophobic core is solubilized, and the carborane in the core of the micelle is given covalent conjunction. Two carborane compounds, carborane with a mono-vinylbenzyl group [1-(4-vinylbenzyl)-closo-carborane (VB-carborane)] and carborane with di-vinylbenzyl groups [1,2-bis(4-vinylbenzyl)-closo-carborane ((VB)2-carborane)], were newly prepared and employed for the core polymerizations. The encapsulation efficiency of the VB-carborane in the micelles is much higher than that of the (VB)2-carborane. This improved efficiency is most likely caused by the interaction of the hydrogen bonding of the VB-carborane with the polymer micelle matrix, while no hydrogen bonding sites remain in the case of the (VB)2-carborane. The obtained core-polymerized and boron-conjugated micelles (PM, which were prepared from VB-carborane) showed extremely high stability under physiological conditions, which suppressed the leakage of boron compounds owing to the existence of the covalent bonds. The accumulation of the PM (7.2 ID% per g) in tumors is much higher than that of the non-polymerized micelles (NPM) (0.7 ID% per g) under the same conditions (at 24 h after injection) because of the enhanced stability of the micelles under physiological conditions. In addition, thermal neutron irradiation experiments indicated significant suppression of the growth of tumor volume in tumor-bearing mice treated with the PM. It is important to note that the PM administered via intravenous injection were excreted almost completely from the major organs, except for the tumor, after a week. Therefore, these boron-conjugated micelles represent a promising approach to the creation of a novel boron carrier for BNCT.
Polymer Journal – Springer Journals
Published: Apr 4, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.